SCHEMBL21390554

SCHEMBL21390554

O=C1COC2CCN(C(=O)N3CC(c4ccc(C(F)(F)F)cc4F)C3)C[C@H]2N1

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 9/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23148887 1.00 MGLL (0.71) MGLL
SCHEMBL29849894 1.00 MGLL (0.71) MGLL
SCHEMBL25785716 0.95 MGLL (0.70) MGLL
SCHEMBL24095543 0.95 MGLL (0.70) MGLL
SCHEMBL23853793 0.90 MGLL (0.63) MGLL
SCHEMBL32685333 0.90 MGLL (0.63) MGLL
SCHEMBL21390254 0.86 MGLL (0.62) MGLL
SCHEMBL23149104 0.86 MGLL (0.73) MGLL
SCHEMBL21390125 0.86 MGLL (0.73) MGLL
SCHEMBL23150511 0.83 MGLL (1.00) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3768684-B1 OXAZINE MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS HOFFMANN LA ROCHE (CH) 2023-02-22 — — EP disclosed
WO-2019180185-A1 OXAZINE MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2019-09-26 — — WO disclosed
Send feedback